Skip to main content
< Back to news
Dr. Jordi Mestres, founder of Chemotargets. Image / Chemotargets.

Chemotargets CLARITY platform, a technological seed of a drug discovery tool from American Chemical Society

Today, CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced the launch of the CAS BioFinder Discovery Platform™, a cutting-edge tool based on CLARITY® technology from the Catalan biotech Chemotargets. The company, based in the Barcelona Science Park, is a global leader in the development of artificial intelligence and prediction platforms for drug discovery and design.

The CAS BioFinder Discovery Platform taps into science content through the CAS Content Collection™, which includes the world’s most comprehensive, highly structured, human-curated scientific data. In addition to connecting biological sequences, structure-activity relationship data, ADME-measurement, and toxicity to its substance collection, CAS more recently incorporated biomarker data linked to diseases and drugs. CAS leveraged Chemotargets CLARITY® as the technological foundation for the CAS BioFinder™ predictive capabilities and analytics.

Pairing this wealth of scientific knowledge with proprietary AI-powered technology and an intuitive, visual interface, the CAS BioFinder Discovery Platform is built to serve drug discovery scientists in their research just like CAS SciFinder® has served chemists and related scientists for decades.

Through the CAS BioFinder Discovery Platform, users can explore empirical data and run predictive models to understand the likely effects of novel molecules. The new platform also includes API access to bioactivity and biomarker data that scientists will be able to process using their in-house models. Over time, users will benefit from fully integrated innovation capabilities that span their spectrum of data, research, and workflow needs.

To ensure that the CAS BioFinder Discovery Platform addresses drug discovery scientists’ most salient pain points, last year CAS assembled a Life Sciences Industry Advisory Board composed of global thought leaders from commercial, academic, and government organizations who have guided the organization’s journey into life sciences. An early version of CAS BioFinder was also shared with several industry partners whose feedback has helped make the solution strong from the start.

Chemotarget’s team at the Barcelona Science Park. Image / Chemotargets.

»  Learn more about the CAS BioFinder Discovery Platform: